NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

Sooner or later DCVax-l name will be known.

Not sure who you are referring to as not knowing about NWBO, but if what you are saying is that NWBO isn't well known on the Street then I am afraid you may be misinformed. This company actually is pretty widely known and, for the most part, laughed at by the professionals in the industry. Imo, pretty much everyone, including the company, knows that the Phase 3 DCVax-L trial failed to meet its primary and secondary endpoints and that the company has failed to share this information with shareholders. There is no product, no revenue, and no timeline for that to change. Assets are being sold off and depleted rapidly. Additionally there is tens of millions in debt and financial obligations, not to mention another 700 million shares of common stock for sale as the float continues to expand by the day (up to 1.2 billion shares approved by shareholders in May).

I think they know all they need to know, frankly.